Social Sciences and Malaria Control


We believe information about products and services that could benefit people should be made available to consumers to help them make informed decisions about their health care. Therefore, we try to provide accurate and reliable information by working with different fact-checkers to review articles for factual accuracy, relevance, and timeliness. A team of qualified and experienced fact-checkers rigorously reviewed our content before publishing it on our website. At TnHealth, we rely on the most current and reputable sources cited in the text and listed at the bottom of each article. Content is fact-checked after it has been edited and before publication.

future image

TnHealth has taken reasonable steps to ensure compliance with regulatory bodies’ guidelines. Our claims in advertisements or sponsorships do not constitute endorsement or recommendation, and the exclusion does not suggest disapproval. TnHealth does not control or guarantee the accuracy, completeness, or efficacy of the information contained in any advertisement or sponsorship. If you believe we have overextended ourselves and are in breach of the advertising guidelines, reach out to our team.

Health Policy and Planning 2002, 17/4 (402-411)

Willingness to pay for treated mosquito nets in Surat, India: The design

and descriptive analysis of a household survey

Bhatia M.R.; Fox-Rushby J.A.

Department of Social Policy, London School of Economics,

Houghton Street, London, WC2A 2AE  United Kingdom

Email: [email protected]

For willingness to pay (WTP) studies to have an appropriate impact on

policy making, it is essential that the design and analysis are undertaken carefully. This

paper aims to describe and justify the design of the survey tool used to assess hypothetical

WTP for treated mosquito nets (TMN) in rural Surat, India and report its findings. Results from

qualitative work were used as an input for developing the WTP questionnaire. A total of 1200

households belonging to 80 villages in rural Surat were selected for the study. A bidding

format was used to elicit WTP values, using three different starting bids. The scenario was

constructed in a way to reduce the possibility of respondents acting strategically.

The response rate was 100%. About 79% of the respondents were willing to buy TMNs

and the mean WTP was Rs57. Descriptive results of economic and other taste and preference

 variables are also presented, which include preventive measures used by households and

treatment seeking behaviour for malaria. It is observed that WTP as well as demographic variables

and prevention methods differ significantly across arms of the trial. This paper suggests that

policy-makers could use the evidence following further analysis, along with information on costs

of implementation, to ascertain the levels of subsidy that may be needed at different levels of coverage.

Health Policy and Planning 2002, 17/4 (333-344)

Self-treatment for malaria: The evidence and methodological issues

McCombie S.C.

Department of Anthropology, Georgia State University, 33

Gilmer Street, Atlanta, GA 30303-3083  United States

Email: [email protected]

Malaria remains an important cause of death, especially in sub-Saharan

Africa. Self-treatment with antimalarial drugs is a common practice  that raises important

issues for policy-makers. A number of important questions concerning factors related to

self-treatment, adequacy of self-treatment and the role of self-treatment in malaria mortality

remain unanswered. Although there are some common patterns, there is considerable diversity

in treatment practices, even within a single country. Social science research on malaria treatment

needs to move beyond description to evaluation of interventions. This will require a greater degree

of methodological rigour and more attention to the generation of data that can be compared across

time periods and studies. Definitions of malaria cases and the role of local disease categories in

identifying cases need to be made more explicit. Illnesses should be classified by severity,

using measures of perceived severity as well as biomedical signs of severity. Each treatment step

should be considered in terms of four levels of analysis: who provided the treatment or advice,

what the treatment was, where it was obtained and when it was taken in relationship to onset of illness. 

Social Science & Medicine.  55(12):2215-26, 2002 Dec.

Strategies to improve adherence to recommended chloroquine treatment

regimes: a quasi-experiment in the context of integrated primary health

care delivery in Ghana.

Agyepong IA. Ansah E. Gyapong M. Adjei S. Barnish G. Evans D.

District Health Administration, PO Box 1, Dodowa, Ghana.

Email: [email protected]

This paper presents the results of an intervention study carried out as part of the activities

of a District Health Management Team responsible for integrated primary health care delivery

in a rural district in Ghana. The aim was to test the impact of a combination of improved information

provision to patients and drug labeling on adherence to recommended anti-malarial treatment

regimens focusing on oral chloroquine, for the outpatient management of acute uncomplicated malaria.

The study had a quasi-experimental pre-test post-test control group design with partly random allocation

by clinic. The results show that the intervention resulted in an improved flow of information to clients

prescribed chloroquine, and better labeling of drugs for the home treatment of acute clinical episodes

of malaria in the intervention area. Improvements in adherence occurred in all clinics. However,

improvements in adherence were most marked in the clinic that was worst performing at the start

of the intervention. Implications of the results for improving adherence to chloroquine therapy on

an outpatient basis are discussed.

Social Science & Medicine.  55(12):2121-30, 2002 Dec.

Investigating starting-point bias: a survey of willingness to pay for

insecticide-treated nets.

Onwujekwe O.  Nwagbo D.

Health Policy Research Unit, Department of Pharmacology and Therapeutics, College of Medicine,

University of Nigeria, Enugu-Campus, Nigeria.
Email: [email protected]

The objective of this study was to investigate the existence of

starting-point bias in the bidding game contingent valuation elicitation technique when determining

 the willingness to pay (WTP) for insecticide-treated nets (ITNs) and ITNs re-treatment in rural Nigeria.

Of all existing contingent techniques, the bidding game most closely mimics the normal price taking

behaviour in local markets in Nigeria. Three different starting-points (low, medium and high) were used

to determine WTP for large and small ITNs, and for ITNs re-treatment, respectively. The respondents

were randomly assigned to any of the starting-points and a pre-tested interviewer-administered questionnaire

used to elicit WTP. Non-parametric tests and the Tobit model were used to analyse the data for evidence of

starting-point bias. Plots of respondents’ cumulative density functions by starting-points were also examined to

show the pattern of responses. The non-parametric tests showed no statistically significant differences between

the three starting points in WTP for large ITNs (p =0.262) and for ITNs re-treatment (p = 0.412). However, there

was a statistical significant difference in WTP for small ITNs (p = 0.045). Nevertheless, in this instance, the high

starting point group had a lower mean WTP than the low group, and also had the lowest median WTP amongst the

three groups. However, using the conditional WTP (only males), there were no differences among the three starting-points for all goods. The multiple regression analyses using the Tobit model confirmed the results of the non-parametric tests. The plots of cumulative densities were also similar for the three starting-points for the three products. However, the high starting-point group had those more willing to pay higher amounts for large and small nets. There was no conclusive evidence of starting-point bias. Future research is required in order to gain a deeper understanding on factors determining peoples’ valuation of goods and services, reasons for any type of starting-point bias, and how the bidding game can be improved.

Am J Epidemiol  2003 Feb 1;157(3):203-9 
Maternally Transmitted Antibodies to Pregnancy-Associated Variant Antigens on the Surface of Erythrocytes Infected with Plasmodium falciparum: Relation to Child Susceptibility to Malaria.
Cot M, Le Hesran JY, Staalsoe T, Fievet N, Hviid L, Deloron P.
Mother and Child Health in the Tropics, Research Institute for Development
(IRD), Hopital Tenon, Paris, France.
The consequences of pregnancy-associated malaria on a child's health have been
poorly investigated. Malarial infection of the placenta seems to result in a
higher susceptibility of children to the parasite during their first year of
life. In 1993-1995, the authors investigated the role of antibodies in variable
surface antigens (VSA) specific to chondroitin sulfate A (CSA)-binding parasites
to assess the parasitologic status of the child. Flow cytometry was used to
measure levels of antibodies to VSA from CSA-selected and -unselected parasite
lines in the cord blood of 79 newborns in Ebolowa, Cameroon. These newborns were
subsequently followed up for 2 years to determine the date of first occurrence
of blood parasites and mean parasite density during follow-up. Maternally
transmitted antibodies to VSA expressed by CSA-binding parasites, but not
antibodies to any other specificity, were negatively related to time of first
appearance of Plasmodium falciparum in a child's blood and were positively
related to mean parasite density during the first 2 years of life. If maternal
infection is thought to be the main mechanism influencing susceptibility of the
newborn to malaria, antibodies to VSA may better denote maternal malaria
infection during almost the entire pregnancy as opposed to placental blood smear
reflecting infection during the last few months of pregnancy.
Parasitol Int  2003 Mar;52(1):81-93 
A mathematical model for the transmission of Plasmodium vivax malaria.
Ishikawa H, Ishii A, Nagai N, Ohmae H, Harada M, Suguri S, Leafasia J.
Department of Environmental and Mathematical Sciences, Faculty of Environmental
Science and Technology, Okayama University, Tsushimanaka, 700-8530, Okayama,
We have proposed a mathematical model for the transmission of Plasmodium vivax
malaria quantitatively, which is adjusted to the infected region, Guadalcanal,
in the Solomon Islands. The simulation of a transmission model will be
instrumental in planning the malaria control strategy. A characteristic of the
life cycle of P. vivax is that a sporozoite injected into the blood stream by a
mosquito bite may sometimes stay in a hepatocyte as a hypnozoite. Therefore, we
have incorporated a phenomenon of renewed infections caused by a relapse into
the transmission model. Also through the simulations we have attempted to
evaluate the decline in prevalence caused by the programs of selective mass drug
administration (MDA) and vector control such as the distribution of
permethrin-treated bednets. The simulations have indicated that the concentrated
repetition of MDA at 1-week intervals would reduce the prevalence of vivax
malaria swiftly in the beginning and would keep the parasite rate below 1% for a
few years but the prevalence would increase thereafter. In contrast, the
parasite rate would remain below 1% for a long time if a trial of 1 or 2 times
MDA is accompanied with some reduction of the vectorial capacity by the
enforcement of vector control. In any case, it is important to beware of relapse
cases because even after the execution of MDA it takes a long time to decrease
the proportion of hypnozoite carriers.
Parasitol Int  2003 Mar;52(1):61-70 
Expansion of unconventional T cells with natural killer markers in malaria
Watanabe H, Weerasinghe A, Miyaji C, Sekikawa H, Toyabe S, Mannor MK, Morshed
SR, Halder RC, Kobayashi J, Toma H, Sato Y, Iwai K, Matsuoka H, Abo T.
Department of Immunology, Niigata University School of Medicine, 951-8510,
Niigata, Japan
Immunological states during human malarial infection were examined. In parallel
with parasitemia and anemia, granulocytosis was induced in the blood of
patients, especially those infected with Plasmodium (P.) falciparum. At that
time, the level of lymphocytes remained unchanged or slightly increased in the
blood. However, the distribution of lymphocyte subsets was modulated, showing
that the proportion of CD56(+)T cells, CD57(+)T cells, and gammadeltaT cells
(i.e. all unconventional T cells) had increased in patients infected with P.
falciparum or P. vivax. This phenomenon occurred at the early phase of infection
and disappeared in the course of recovery. The data from patients with multiple
attacks of P. vivax infection showed that there was no augmentation of these
responses. In adult cases, the increase in the proportion of unconventional T
cells seemed to closely parallel disease severity. However, all these responses
were weak in children, even those infected with P. falciparum. In conjunction
with accumulating evidence from mouse malaria experiments, the present results
suggest that the immunological state induced by malarial infection might mainly
be an event of unconventional T cells and that the immunological memory might
not be long-lasting, possibly due to the properties of unconventional T cells.
Parasitol Int  2003 Mar;52(1):53-9 
Oral artesunate prevents Plasmodium berghei Anka infection in mice.
Gumede B, Folb P, Ryffel B.
Department of Pharmacology, University of, Cape Town, South Africa
Artesunate, a semi-synthetic derivative of a naturally occurring anti-malarial
artemisinin was compared with chloroquine in C57BL/6 mice infected with
Plasmodium berghei Anka (PbA). A 7-day oral administration of artesunate
prevented parasitaemia at 10 mg/kg/day. However, recrudescence of parasitaemia
and cerebral malaria occurred upon cessation of treatment followed by death
within 28 days. However, a 14-day course of artesunate (100 mg/kg/day) prevented
completely the development of parasitaemia and cerebral malaria with a survival
of more than 60-days as did 10 mg/kg/day chloroquine. These data demonstrate
that oral artesunate inhibits PbA and prevents cerebral malaria, but needs to be
administered at high dose and for prolonged time to eradicate PbA infection in
Parasitol Int  2003 Mar;52(1):41-52 
Characterisation of a sexual stage-specific gene encoding ORC1 homologue in the human malaria parasite Plasmodium falciparum.
Li JL, Cox LS.
Department of Biochemistry, University of Oxford, South Parks Road, OX1 3QU,
Oxford, UK
The origin recognition complex (ORC) is a multisubunit protein composed of six
polypeptides that binds to replication origins and is essential for the
initiation of chromosomal DNA replication. Using the Vectorette technique, we
have isolated a novel gene encoding an ORC1-like protein from the human malaria
parasite Plasmodium falciparum. The gene has no introns and encodes a protein
(PfORC1) of 1189 amino acid residues with a predicted molecular mass of 139 kDa.
PfORC1 contains all conserved sequences in the ORC1/Cdc6/Cdc18 family and
displays the highest homology to the Schizosaccharomyces pombe ORC1. However,
PfORC1 possesses an extensive N-terminal segment with several interesting
features including multiple potential phosphorylation sites, a large proportion
of charged amino acids, four copies of a heptamer repeat, two nuclear
localisation signals, and a leucine zipper motif. Southern blot analyses show
that the Pforc1 gene is present as a single copy per haploid genome and is
located on chromosome 12. A 5600 nucleotide transcript of this gene is expressed
predominantly in the sexual erythrocytic stage, indicating that PfORC1 may be
involved in gametogenesis during which DNA is quickly replicated.
Parasitol Int  2003 Mar;52(1):1-11 
Transmission-blocking vaccine of vivax malaria.
Tsuboi T, Tachibana M, Kaneko O, Torii M.
Department of Molecular Parasitology, Ehime University School of Medicine,
Shigenobu-cho, 791-0295, Ehime, Japan
Malaria remains one of the leading causes of both morbidity and mortality of
humans residing in tropical countries. For many malarious regions outside of
Africa, development of effective transmission-blocking vaccines will require
coverage against both Plasmodium falciparum and Plasmodium vivax. The genes
coding for two potential P. vivax transmission-blocking antigens, Pvs25 and
Pvs28, have been cloned. Mice vaccinated with yeast-produced recombinant
proteins Pvs25 and Pvs28 adsorbed to aluminum hydroxide developed strong
antibody responses against the immunogens. The development of oocysts in
mosquitoes was completely inhibited when these antisera were ingested with the
P. vivax Salvador (Sal) I strain-infected chimpanzee blood. In a large
collection of P. vivax field isolates, we found only 5 nucleotide changes that
would result in amino acid substitutions in Pvs25. In contrast, the Pvs28 gene
had 22 nucleotide changes that would result in conservative amino acid
substitutions. How the antigenic polymorphism of Pvs25 and Pvs28 would affect
the efficacy of Sal I based vaccine remains to be elucidated. Clinical trials
with Pvs25 and the P. falciparum ortholog Pfs25 are in preparation.
Cell Microbiol  2003 Jan;5(1):3-14 
Insect immunity and its implication in mosquito-malaria interactions.
Dimopoulos G.
Centre for Molecular Microbiology and Infection, Department of Biological
Sciences, Imperial College of Science, Technology and Medicine, SW7 2AZ London,
Insects' resistance to infectious agents is essential for their own survival and
also for the health of the plant, animal and human populations with which they
closely interact. Several of the major human diseases are spread by insects and
are rapidly expanding as a result of the development of insecticide resistance
in vectors and drug resistance in parasites. A vector insects' permissiveness to
a pathogen, and hence the spread of the disease, will largely depend on the
compatibility of the molecular interactions between the two species and the
capability of the insect immune system to recognize and kill the pathogen. The
innate immune system comprises a variety of components and mechanisms that can
discriminate between different microorganisms and mount specific responses to
control pathogenic infections. An impressive body of knowledge on the insects'
innate immunity has been generated from studies in the model organism
Drosophila. These studies are now guiding the exploration of the immune system
in the vector mosquito of human malaria, Anopheles, and its implication in the
elimination of parasites. Anopheles immune responses have been linked to
parasite losses and some refractory mosquitoes can kill all parasites through
specific defence mechanisms. The recently sequenced Drosophila and Anopheles
genomes provide a detailed and comparative view on their immune gene repertoires
that in combination with post-genomic analyses is used to further dissect the
complex mechanisms of Plasmodium killing in the mosquito.
J Am Mosq Control Assoc  2002 Dec;18(4):359-63 
Colonization of Anopheles maculatus from Central Java, Indonesia.
Bangs MJ, Soelarto T, Barodji, Wicaksana BP, Boewono DT.
US Naval Medical Research Unit No. 2, Kompleks P2M/LitBangKes, Jl. Percertakan
Negara No. 29, Jakarta, 10560 Indonesia.
The routine colonization of Anopheles maculatus, a reputed malaria vector from
Central Java, is described. The strain is free mating and long lived in the
laboratory. This species will readily bloodfeed on small rodents and artificial
membrane systems. Either natural or controlled temperatures, humidity, and
lighting provide acceptable conditions for continuous rearing. A simple larval
diet incorporating a 10:4 powdered mixture of dried beef and rice hulls proved
acceptable. Using a variety of simple tools and procedures, this colony strain
appears readily adaptable to rearing under most laboratory conditions. This
appears to be the first report of continuous colonization using a free-mating
strain of An. maculatus. Using this simple, relatively inexpensive method of
mass colonization adds to the short list of acceptable laboratory populations
used in the routine production of human-infecting plasmodia.
J Am Mosq Control Assoc  2002 Dec;18(4):329-40 
The potential of intermittent irrigation for increasing rice yields, lowering
water consumption, reducing methane emissions, and controlling malaria in
African rice fields.
Keiser J, Utzinger J, Singer BH.
Office of Population Research, Princeton University, Princeton, NJ 08544, USA.
Rice production in sub-Saharan Africa has more than doubled in the last 3
decades and the potential to further develop rice-harvested areas is
considerable. Several studies have demonstrated that the transformation of
arable land into rice irrigation might create suitable habitats for large
populations of disease vectors. Prominent among those are anopheline mosquitoes
responsible for transmission of malaria. The method of irrigation on an
intermittent basis during the rice-cropping calendar has gained renewed interest
as a potentially effective malaria control strategy since the early 1980s. We
review the experiences of the past 80 years with intermittent irrigation in the
cultivation of rice. This method has been shown to reduce significantly the
density of malaria vectors by curtailing their larval development. Furthermore,
reduced methane emissions and water savings with at least equal yields were
achieved in intermittently irrigated rice fields. We explore and discuss under
what conditions intermittent irrigation might be beneficial in new rice-growing
areas and identify steps that have to be taken to expand such programs in the
Malar J  2002 Dec 18;1(1):19 [epub ahead of print] 
MalariaSphere: A greenhouse-enclosed simulation of a natural Anopheles
gambiae (Diptera: Culicidae) ecosystem in western Kenya.
Knols BG, Njiru BN, Mathenge EM, Mukabana WR, Beier JC, Killeen GF.
International Centre of Insect Physiology and Ecology (ICIPE), Mbita Point
Research & Training Centre, PO Box 30, Mbita Point, Kenya. 
Email: [email protected]
BACKGROUND: The development and implementation of innovative vector control
strategies for malaria control in Africa requires in-depth ecological studies in
contained semi-field environments. This particularly applies to the development
and release of genetically-engineered vectors that are refractory to Plasmodium
infection. Here we describe a modified greenhouse, designed to simulate a
natural Anopheles gambiae Giles ecosystem, and the first successful trials to
complete the life-cycle of this mosquito vector therein. METHODS: We constructed
a local house, planted crops and created breeding sites to simulate the natural
ecosystem of this vector in a screen-walled greenhouse, exposed to ambient
climate conditions, in western Kenya. Using three different starting points for
release (blood-fed females, virgin females and males, or eggs), we allowed
subsequent stages of the life-cycle to proceed under close observation until one
cycle was completed. RESULTS: Completion of the life-cycle was observed in all
three trials, indicating that the major life-history behaviours (mating, sugar
feeding, oviposition and host seeking) occurred successfully. CONCLUSION: The
system described can be used to study the behavioural ecology of
laboratory-reared and wild mosquitoes, and lends itself to contained studies on
the stability of transgenes, fitness effects and phenotypic characteristics of
genetically-engineered disease vectors. The extension of this approach, to
enable continuous maintenance of successive and overlapping insect generations,
should be prioritised. Semi-field systems represent a promising means to
significantly enhance our understanding of the behavioural and evolutionary
ecology of African malaria vectors and our ability to develop and evaluate
innovative control strategies. With regard to genetically-modified mosquitoes,
development of such systems is an essential prerequisite to full field releases.
Int J Health Geogr  2002 Dec 9;1(1):4 [epub ahead of print] 
The application of geographical information systems to important public health problems in Africa.
Tanser FC, Le Sueur D.
The National Malaria Programme, Medical Research Council, PO Box 70380, Overport
4067, Durban, South Africa. 
Email: [email protected]
Africa is generally held to be in crisis, and the quality of life for the
majority of the continent's inhabitants has been declining in both relative and
absolute terms. In addition, the majority of the world's disease burden is
realised in Africa. Geographical information systems (GIS) technology,
therefore, is a tool of great inherent potential for health research and
management in Africa. The spatial modelling capacity offered by GIS is directly
applicable to understanding the spatial variation of disease, and its
relationship to environmental factors and the health care system. Whilst there
have been numerous critiques of the application of GIS technology to developed
world health problems it has been less clear whether the technology is both
applicable and sustainable in an African setting. If the potential for GIS to
contribute to health research and planning in Africa is to be properly evaluated
then the technology must be applicable to the most pressing health problems in
the continent. We briefly outline the work undertaken in HIV, malaria and
tuberculosis (diseases of significant public health impact and contrasting modes
of transmission), outline GIS trends relevant to Africa and describe some of the
obstacles to the sustainable implementation of GIS. We discuss types of viable
GIS applications and conclude with a discussion of the types of African health
problems of particular relevance to the application of GIS.
Cochrane Database Syst Rev  2003;(1):CD000169 
Drugs for preventing malaria-related illness in pregnant women and death
in the newborn (Cochrane Review).
Garner P, Gulmezoglu AM.
International Health Research Group, Liverpool School of Tropical Medicine,
Pembroke Place, Liverpool, UK, L3 5QA. 
Email: [email protected]
BACKGROUND: Malaria contributes to maternal illness and anaemia in pregnancy,
especially in first-time mothers, and could harm the mother and the baby.
Interventions to prevent or mitigate the effects of malaria during pregnancy are
often recommended. OBJECTIVES: To assess drugs given to prevent malaria
infection and its consequences in pregnant women living in malarial areas.
SEARCH STRATEGY: We searched the Cochrane Infectious Diseases Group trials
register (July 2002); the Cochrane Controlled Trials Register (Issue 3, 2002);
MEDLINE (1966-July 2002); EMBASE (1974-July 2002); and LILACS (accessed July
2002). We contacted researchers in the field. SELECTION CRITERIA: Randomised 
and quasi-randomised trials in pregnant women of drugs given regularly that aim to
mitigate the effects of malaria in pregnancy. DATA COLLECTION AND ANALYSIS:
Trial quality was assessed. Data extraction was done by two reviewers using
standard criteria. MAIN RESULTS: 14 trials included (n=3454); only 2 were
adequately concealed. For women of all parity groups, the meta-analysis (n=2890)
showed lower parasitaemia and placental malaria in the intervention arm. For
women having the first or second baby, there were 9 studies (n=3454). Severe
antenatal anaemia was less common (RR 0.62, 95%CI 0.50 to 0.78, 4 studies),
perinatal mortality appeared lower (RR 0.73, 95% CI 0.73 to 0.99, 3 studies).
Maternal parasitaemia was lower with the intervention (RR 0.24, 95%CI 0.14 to
0.42, random effects model, 6 studies), and mean birthweight higher (WMD 122 g,
95%I 81 to 164 g, 8 studies), and low birthweight was less common (RR 0.49,
95%CI 0.36 to 0.65, 6 studies). REVIEWER'S CONCLUSIONS: Drugs given routinely
for malaria during pregnancy reduce severe antenatal anaemia in the mother, and
are associated with higher birthweight and probably reduced perinatal mortality.
This effect appears to be limited to low parity women.
Cochrane Database Syst Rev  2003;(1):CD000129 
Vaccines for preventing malaria (Cochrane Review).
Graves P, Gelband H.
1400 W. Oak Street, Fort Collins, USA, CO 80521. 
Email [email protected] or [email protected]
BACKGROUND: Four types of malaria vaccine, SPf66 and MSP/RESA vaccines
(against the asexual stages of the Plasmodium parasite) and CS-NANP and 
RTS,S vaccines (against the sporozoite stages), have been tested in randomized
Controlled trials in endemic areas. OBJECTIVES: To assess malaria vaccines against
Plasmodium falciparum, P. vivax, P. malariae and P ovale in preventing
infection, disease and death. SEARCH STRATEGY: We searched the Cochrane
Infectious Diseases Group trials register (July 2002), the Cochrane Controlled
Trials Register (The Cochrane Library Issue 2, 2002), MEDLINE (1966 to July
2002), EMBASE (1980 to May 2002), Science Citation Index (1981 to July 2002),
and reference lists of articles. We also contacted organizations and researchers
in the field. SELECTION CRITERIA: Randomized controlled trials comparing
vaccines against Plasmodium falciparum, P. vivax, P. malariae or P. ovale with
placebo or routine antimalarial control measures in people of any age receiving
a challenge malaria infection. DATA COLLECTION AND ANALYSIS: Two reviewers
independently assessed trial quality and extracted data. MAIN RESULTS: Eighteen
efficacy trials involving 10,971 participants were included. There were ten
trials of SPf66 vaccine, four trials of CS-NANP vaccines, two trials of RTS,S
vaccine, and two of MSP/RESA vaccine. Results with SPf66 in reducing new malaria
infections (P. falciparum) were heterogeneous: it was not effective in four
African trials (Peto odds ratio (OR) 0.96, 95% confidence interval (CI) 0.81 to
1.14), but in five trials outside Africa the number of first attacks was reduced
(Peto OR 0.77, 95% CI 0.67 to 0.88). Trials to date have not indicated any
serious adverse events with SPf66 vaccine. In three trials of CS-NANP vaccines,
there was no evidence for protection by these vaccines against P. falciparum
malaria (Peto OR 1.12, 95% CI 0.64 to 1.93). In a small trial in non-immune
adults in the USA, RTS,S gave strong protection against experimental infection
with P. falciparum. In a trial in an endemic area of the Gambia in semi-immune
people, there was a reduction in clinical malaria episodes in the second year of
follow up, corresponding to a vaccine efficacy of 66% (CI 14% to 85%). In a
trial in Papua New Guinea, MSP/RESA had no protective effect against episodes of
clinical malaria. There was evidence of an effect on parasite density, but this
differed according to whether the participants had been pretreated with
sulfadoxine/pyrimethamine or not. The prevalence of infections with the parasite
subtype of MSP2 in the vaccine was reduced compared with the other subtype (Peto
OR 0.35, CI 0.23 to 0.53). REVIEWER'S CONCLUSIONS: There is no evidence for
protection by SPf66 vaccines against P. falciparum in Africa. There is a modest
reduction in attacks of P. falciparum malaria following vaccination with SPf66
in other regions. Further research with SPf66 vaccines in South America or with
new formulations of SPf66 may be justified. There was not enough evidence to
evaluate the use of CS-NANP vaccines. The RTS,S vaccine showed promising result,
as did the MSP/RESA vaccine, but it should include the other main allelic form
of MSP2. The MSP/RESA trial demonstrated that chemotherapy during a vaccine
trial may reduce vaccine efficacy, and trials should consider very carefully
whether this practice is justified.
Trop Med Int Health  2003 Jan;8(1):48-55 
Malaria control in complex emergencies: the example of East Timor.
Kolaczinski J, Webster J.
Disease Control and Vector Biology Unit, London School of Hygiene and Tropical
Medicine, London, UK Ministry of Health, Dili, East Timor HealthNet
International, Dili, East Timor.
Malaria control in complex emergencies forms part of the World Health
Organization's Roll Back Malaria (RBM) initiative. The underlying principle is a
partnership with other UN agencies and non-governmental organizations, with the
RBM programme providing support to its implementing partners through a Technical
Support Network. This innovative approach was applied for the first time in
1999-2000, following the return of stability and security to East Timor. The RBM
programme assessed the malaria situation during the acute emergency phase and
identified programme priorities. Two non-governmental organizations were
subsequently invited to operate as implementing partners. Individual proposals
were developed and funding obtained, but no overall organizational and planning
framework was established. Implementation commenced quickly, addressing aspects
of prevention, diagnosis and treatment. As East Timor progressed into the
transitional phase towards independence, the programme was not realigned to the
changing context. Absence of monitoring and evaluation was a significant factor
contributing to the resulting continuation of emergency malaria control
activities well into the transitional phase. East Timor's example of malaria
control in complex emergencies provides important lessons: (i) partnership roles
and responsibilities should be clearly defined from the beginning of the
programme, (ii) planning, monitoring and evaluation should be instigated from
the start with the aim to develop long-term strategies and policies, (iii)
expert support is necessary to guide implementation at all stages, (iv) the
flexibility to react to changing priorities should be ensured as the context of
the emergency and the available health structure changes, and (v) the
implementation process, and alternatives for continuation of activities once the
RBM complex emergency partnership has terminated, should be clarified to all
partners involved.
Trop Med Int Health  2003 Jan;8(1):37-47 
Efficacy and efficiency of new Bacillus thuringiensis var. israelensis and
Bacillus sphaericus formulations against Afrotropical anophelines in Western Kenya.
Fillinger U, Knols BG, Becker N.
International Centre of Insect Physiology and Ecology (ICIPE), Mbita Point,
Kenya Laboratory of Entomology, Wageningen University Research Centre,
Wageningen, The Netherlands German Mosquito Control Association (KABS), Waldsee, Germany.
We evaluated the efficacy of new water-dispersible granular (WDG) formulations
of Bacillus thuringienis var. israelensis (Bti; VectoBac(R)) and B. sphaericus
(Bs; VectoLex(R), Valent BioScience Corp., Illinois, USA) for the control of
larval Anopheles gambiae sensu lato Giles mosquitoes in a malaria-endemic area
around Lake Victoria, Western Kenya. WDG and powder formulations were compared
in laboratory bioassays and followed by efficiency and residual effect
assessments of both WDG formulations in open field experiments. LC50 and LC95
values for the Bti/Bs strains and their formulations show high susceptibility of
A. gambiae sensu stricto under laboratory conditions. The larvae proved more
susceptible to Bs than to Bti and the WDG formulations were slightly superior to
the powder formulations. High efficiency was also shown in the open field
trials, and a minimum dosage of 200 g/ha Bti WDG, representing the LC95 of the
laboratory tests, was sufficient to fully suppress emergence of mosquitoes when
applied at weekly intervals. Bti WDG did not show a residual effect,
irrespective of the concentration applied. The Bs WDG formulation, however,
showed significant larval reductions up to 11 days post-treatment at application
doses of either 1 or 5 kg/ha. We conclude that the main malaria vector in our
study area is highly susceptible to these microbial control agents. Minimum
effective dosages to achieve elimination of the larval population in a given
habitat are extremely low and environmental impact is negligible. Microbial
products for larval control have therefore great potential within Integrated
Vector Management programmes and may augment control efforts against adult
vector stages, such as the use of insecticide-treated bednets, in many parts of
Trop Med Int Health  2003 Jan;8(1):30-32 
Myocardial damage in falciparum malaria detectable by cardiac troponin T is
Gunther A, Grobusch MP, Slevogt H, Abel W, Burchard GD.
Institut fur Tropenmedizin, Charite, Humboldt-Universitat zu Berlin, Germany
Institut fur Tropenmedizin, Eberhard-Karls-Universitat, Tubingen, Germany
Medizinische Klinik mit Schwerpunkt Infektiologie, Charite Campus Virchow,
Humbold-Universitat zu Berlin, Germany Abteilung fur Laboratoriumsmedizin am
Unfallkrankenhaus Berlin, Germany.
OBJECTIVES: To estimate the prevalence of myocardial damage in falciparum
malaria by serum concentration of cardiac troponin T. METHODS: Retrospective
study of stored sera and patient files; assessment of acute myocardial damage by
serum concentration or activity of cardiac troponin T, creatine kinase, creatine
kinase MB and myoglobin and by routine electrocardiography. RESULTS: A total of
161 patients with falciparum malaria were included in the study; troponin T was
elevated in one case (0.6%), no CK-MB elevations were found, myoglobin was
elevated in 10 of 161 patients (6.2%), all of whom were elderly and had
concomitant elevated serum concentration levels of cystatin C; ECG abnormalities
were seen in 23 patients. CONCLUSION: Assessed by troponin T, myocardial damage
in falciparum malaria is rare.
Trop Med Int Health  2003 Jan;8(1):19-24 
Therapeutic efficacy of chloroquine plus sulphadoxine/ pyrimethamine compared 
with monotherapy with either chloroquine or sulphadoxine/pyrimethamine in 
uncomplicated Plasmodium falciparum malaria in Laos.
Schwobel B, Jordan S, Vanisaveth V, Phetsouvanh R, Christophel EM, Phompida S,
Von Sonnenburg F, Jelinek T.
Department of Infectious Diseases and Tropical Medicine, University of Munich,
Munich, Germany Center of Malariology, Parasitology and Entomology (CMPE),
Ministry of Health, Vientiane, Lao PDR WHO Laos Office, Vientiane, Lao PDR.
In a southern border province of Lao PDR, we compared the efficacy of
antimalarial drug combinations in patients aged >/=1 year with uncomplicated
Plasmodium falciparum malaria: monotherapy with either mefloquine (MQ),
chloroquine (CQ), or sulphadoxine/pyrimethamine (SP) vs. the combination of both
CQ and SP. Follow-up time was 14 days. Of 265 P. falciparum positive patients,
119 were enrolled in the drug trial. Significantly more patients treated with CQ
than with SP developed early or late treatment failure [44.8%vs. 17.9%, relative
risk (RR) = 2.51, 95% CI 1.03-6.12]. In the SP group, 82.1% were sensitive and
17.9% were treatment failures. The combination treatment CQ plus SP resulted in
83.3% sensitivity and 16.7% treatment failures. Combination treatment has no
advantage over monotherapy with SP (RR = 1.01, 95% CI 0.8-1.3). All patients who
received MQ for treatment (total dose 25 mg/kg) were cured within the 14 days of
follow-up. The findings of this study suggest that use of CQ as first-line
treatment of uncomplicated malaria in the Lao PDR has to be reconsidered. The
combination of both CQ and SP has been discussed as a cost-effective alternative
treatment, but in our patient population achieved no better results than single
therapy with SP.
Trop Med Int Health  2003 Jan;8(1):17-18 
Malaria and amphetamine 'horse tablets' in Thailand.
Newton PN, Chierakul W, Ruangveerayuth R, Abhigantaphand D, Looareesuwan S,
White NJ.
Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand Centre for
Tropical Medicine, Nuffield Department of Medicine, John Radcliffe Hospital,
Oxford, UK Mae Sot Hospital, Mae Sot, Tak Province, Thailand Division of
Narcotics, Department of Medical Sciences, Ministry of Public Health, Bangkok,
During recent clinical malaria research in Thailand we found a high frequency of
amphetamine misuse and withdrawal amongst patients admitted to hospital with
Plasmodium falciparum malaria. This comorbidity may cause diagnostic confusion,
alter malaria pathophysiology and lead to drug interactions.
Trop Med Int Health  2003 Jan;8(1):12-16 
Seizure disorders among relatives of Kenyan children with severe falciparum malaria.
Versteeg AC, Carter JA, Dzombo J, Neville BG, Newton CR.
Faculty of Medicine, Academic Medical Centre, University of Amsterdam,
Amsterdam, The Netherlands Neurosciences Unit, Institute of Child Health,
University of London, UK Centre for Geographic Medicine Research (Coast), Kenya
Medical Research Institute, Kilifi, Kenya.
PURPOSE: The cause of seizures in children with falciparum malaria is unclear.
In malaria endemic areas, children who develop severe falciparum malaria with
seizures may have a genetically higher risk of epilepsy or febrile seizures. We
used the history of seizures in relatives of children previously admitted with
malaria to determine if there is evidence for a familial predisposition of
seizures in children admitted with malaria and seizures or cerebral malaria.
METHODS: Family history of seizures were obtained from the parents/guardians of
81 children (35 children previously admitted with severe malaria and 46 children
matched for age who had not been admitted with severe malaria). Data were
collected on frequency, duration, age of onset, presence of fever and causes of
seizures. RESULTS: The prevalence of seizures in the relatives of children not
admitted with severe malaria was 4.3%, of whom 2.2% had a history of seizures
compatible with febrile seizures, and 1.1% with epilepsy. Overall the odds ratio
(OR) for relations of children admitted with malaria, to have a seizure disorder
was 1.41 [95% confidence interval (CI) 1.06-1.88]. There was a significant risk
of the relatives dying if they had epilepsy [relative risk 1.88 (95% CI
1.11-3.19)], but not for other seizure disorders (i.e. febrile, single or
unclassifiable seizures). CONCLUSION: Relatives of children admitted with severe
falciparum malaria are more likely to have a seizure disorder compared with
controls, but it is unclear if this is because of a genetic propensity or caused
by exogenous factors such as malaria.
Trop Med Int Health  2003 Jan;8(1):3-11 
Plasmodium falciparum multiple infections in Mozambique, its relation to other
malariological indices and to prospective risk of malaria morbidity.
Mayor A, Saute F, Aponte JJ, Almeda J, Gomez-Olive FX, Dgedge M, Alonso PL.
Centro de Investigacao em Saude da Manhica (CISM)/Ministerio de Saude, Maputo,
Mozambique Unidad de Epidemiologia y Bioestadistica, Hospital Clinic, Barcelona,
Spain Instituto Nacional de Saude, Ministerio de Saude, Maputo, Mozambique
Programa Nacional de Control de Malaria, Ministerio de Saude, Maputo,
We describe the frequency of Plasmodium falciparum clones infecting individuals
living in a rural area of southern Mozambique and analyse the relationship
between multiplicity of infection, age and other malariometric indices,
including prospective risk of clinical malaria. The genotyping was based on the
use of restriction fragment length polymorphism-polymerase chain reaction
(RFLP-PCR) analysis of P. falciparum merozoite surface protein 2 (msp2). We
analysed 826 samples collected during five cross-sectional surveys from
residents of Manhica ranging in age from 4 months to 83 years. We also
determined the multiplicity of infection in samples obtained from 6-month-old
infants (n = 79) and children <10 years (n = 158) who were then treated and
followed prospectively for 1 year or 75 weeks, respectively. Multiplicity of
infection did not vary significantly during the first year of life, but
increased thereafter, and decreased during adulthood to the levels found in
infants. With increasing multiplicity of infection, there was a statistically
significant decrease in the risk of submicroscopic infections. There was also a
significant correlation between multiplicity of infection and parasite density
in infants, children <4 years of age and adults, suggesting that high densities
increase the probability of discriminating more clones in complex infections. We
found that the relationship between multiple infections and malaria morbidity is
age-dependent. In infants, the risk of subsequent episodes of clinical malaria
was related to the parasite density but not to baseline multiplicity of
infection. In older children, however, the more clones a child carried, the more
likely they were to have a clinical malaria episode, and this was true after
adjusting for parasite densities. This change in the association between
multiplicity and risk of clinical malaria may indicate a shift in the host
response to P. falciparum.
Emerg Infect Dis  2003 Jan;9(1):33-6 
A molecular surveillance system for global patterns of drug resistance in
imported malaria.
Labbe AC, Patel S, Crandall I, Kain KC.
Analysis of imported malaria in travelers may represent a novel surveillance
system for drug-resistant malaria. We analyzed consecutive falciparum malaria
isolates from Canadian travelers from 1994 to 2000, for polymorphisms in pfcrt,
dhfr, and dhps linked to chloroquine and pyrimethamine/sulfadoxine resistance.
Forty percent of isolates possessed the K76 pfcrt allele, suggesting that many
imported falciparum infections are still responsive to chloroquine. Travelers
who had recently taken chloroquine had a significantly increased risk of
harboring isolates with pfcrt resistance alleles (odds ratio = 4.47; p=0.03).
The presence of two or more mutations in dhfr or dhps was found in 64.8% (95%
confidence interval [CI] 54.6 to 73.9) and in 30.4% (95% CI 21.7 to 40.3) of
isolates, respectively, and increased significantly over the course of the
study. These molecular markers indicate that pyrimethamine/sulfadoxine
resistance is increasing and is now too high to rely on this drug as a routine
therapeutic agent to treat malaria in travelers.
Adv Parasitol  2002;52:235-64 
The consequences of reducing transmission of Plasmodium falciparum in Africa.
Snow RW, Marsh K.
Centre for Tropical Medicine, University of Oxford, John Radcliffe Hospital,
Headington, Oxford, OX3 9DU, UK.
Malaria transmission intensity in Africa varies over several log orders, from
less than one infected bite per year to more than one thousand. In this review
we examine the consequences in terms of age pattern, clinical spectrum and
overall burden of disease and discuss the possible implications for
interventions that reduce exposure to infected bites. With very low transmission
intensity, all age groups are susceptible to severe malaria. With increasing
transmission intensities, older children and adults suffer less severe disease
and with high transmission rates the majority of severe cases occur in infants
under one year of age. This pattern reflects the increasingly rapid acquisition
of immune responses that limit the life-threatening effects of malaria with
increasing exposure to the parasite. The clinical spectrum of severe malaria
varies with transmission: with high transmission, severe malarial anaemia
dominates and cerebral malaria is rare. As one moves towards lower transmission
rates, cerebral malaria accounts for an increasingly large proportion of cases.
Although the population risk of severe disease falls with age, the risk of death
at an individual level may rise with age after an initial fall from very high
case fatality rates in children aged under 6 months. Of central interest to
malaria control is how the overall amount of disease in childhood varies with
transmission. Data from a number of sources suggest that, with low transmission,
the amount of malarial disease rises with increasing exposure but that this
saturates relatively early. A key issue is whether the same pattern obtains for
deaths, both those directly due to malaria and those from all causes. The
methodological limitations of ecological comparisons between different areas are
discussed before presenting a review of attempts to use this approach in Africa.
This suggests that children living in areas of low malarial endemicity have
all-cause mortality rates about half of those of children living in areas of
moderate to high transmission. Deaths in the first year of life rise linearly
with increasing exposure to malaria over a wide range of transmission
intensities; by contrast all-cause mortality in children aged 0-4 years appears
to saturate at relatively low transmission intensities. These data suggest that
interventions that reduce exposure to malaria parasites, such as
insecticide-treated bed nets (ITNs), will have the greatest chance of a
sustained effect when used in areas where disease burdens are high but the
frequency of parasite exposure is low-to-moderate. In conditions of high
transmission, initial reductions in mortality may prove difficult to sustain as
the reduced level of transmission may still lie on the part of the curve where
mortality has saturated. However, at all levels of transmission the overall
balance of benefits, including reduced load on families and health services from
non-life-threatening malaria, favours the widespread introduction of ITNs in
endemic areas of Africa.
Am J Trop Med Hyg  2002 Dec;67(6):611-6 
Genetic diversity of Plasmodium falciparum field samples from an isolated
Colombian village.
Gomez D, Chaparro J, Rubiano C, Rojas MO, Wasserman M.
Laboratory of Biochemistry, Instituto Nacional de Salud, Bogota, Colombia.
Colombian field isolates of Plasmodium falciparum were analyzed for genetic
diversity. Fifty-three samples were collected as thick smears from patients
living in Pangui, an isolated area with low migration. While the samples were
being collected, Pangui was experiencing an epidemic outbreak of malaria. The
samples were typified using nested polymerase chain reaction (PCR) amplification
of block 2 of the merozoite surface protein 1 (MSP1) gene and nested PCR with
mutation-specific primers for position 108 of the dihydrofolate reductase enzyme
gene. The results for the circulating population of parasites in Pangui show low
diversity--four allelic forms--using MSP1 as a marker, a fact that contrasts
with data reported for certain Asian and African zones. A high percentage of
mixed infections was observed, as was high complexity of the infection. No
differential distributions were found for any allelic type.
Am J Trop Med Hyg  2002 Dec;67(6):604-10 
Impact of preseason treatment on incidence of falciparum malaria and parasite 
density at a site for testing malaria vaccines in Bandiagara, Mali.
Coulibaly D, Diallo DA, Thera MA, Dicko A, Guindo AB, Kone AK, Cissoko Y,
Coulibaly S, Djimde A, Lyke K, Doumbo OK, Plowe CV.
Malaria Research and Training Center, Faculty of Medicine, Pharmacy and
Dentistry, University of Mali, Bamako, Mali, West Africa.
Treating malaria before immunizing has been standard in malaria vaccine field
trials. To assess the impact of this practice on subsequent infection and
disease incidence, we conducted a randomized cohort study in Bandiagara, Mali.
Subjects received a treatment dose of sulfadoxine-pyrimethamine (SP) or no
treatment at the beginning of the transmission season. Cumulative and
age-specific incidence of clinical episodes was similar between the 2 groups,
but SP treatment delayed the median time to first clinical episode from 38.5 to
68 days, and after this initial period of protection, disease incidence in the
SP group quickly surpassed the incidence in the untreated group. Parasite
densities during disease episodes were lower in the SP group. SP was chosen as
the drug for initial parasite clearance for the following reasons: 1) it has
been used in previous vaccine trials; 2) our studies have found it to have >99%
efficacy in treating uncomplicated malaria in Mali compared to 85-90% efficacy
for chloroquine in this area; 3) SP is the approved second-line antimalarial
agent in Mali; and 4) its single-dose regimen ensures compliance when treatment
is directly observed.
Am J Trop Med Hyg  2002 Dec;67(6):597-603 
Low antibody responses to variant surface antigens of Plasmodium falciparum 
are associated with severe malaria and increased susceptibility to malaria attacks
in Gabonese children.
Tebo AE, Kremsner PG, Piper KP, Luty AJ.
Department of Parasitology, Institute for Tropical Medicine, University of
Tubingen, Tubingen, Germany.
We measured the levels of IgG antibodies with specificity for the variant
surface antigens (VSA) of Plasmodium falciparum in plasma samples from a cohort
of Gabonese children participating in a longitudinal case-control malaria study.
Children with mild malaria had significantly higher anti-VSA IgG responses than
their matched counterparts with severe malaria, most markedly during
convalescence and when they were healthy. Over the course of the study, almost
twice as many children who presented initially with mild rather than severe
malaria developed antibodies recognizing the VSA expressed by each of a panel of
three isolates, and those with the highest anti-VSA IgG responses had the lowest
malaria attack rates. The results suggest that the clinical outcome of P.
falciparum infection in young African children depends on their ability to both
develop and maintain a broad profile of anti-VSA IgG antibodies, and that this
ability is diminished in children who have experienced a severe malaria attack.
Am J Trop Med Hyg  2002 Dec;67(6):586-96 
Cytokine responses during acute simian Plasmodium cynomolgi and Plasmodium
knowlesi infections.
Praba-Egge AD, Montenegro S, Cogswell FB, Hopper T, James MA.
Department of Tropical Medicine and Parasitology, Tulane University School of
Public Health and Tropical Medicine, New Orleans, Louisiana 70112, USA.
Experimental infection of non-human primates with simian malaria parasites
offers a controlled system to study malarial immunity. Plasmodium cynomolgi (P.
vivax-like) and P. knowlesi (P. falciparum-like) infections in the rhesus monkey
were used as a model to test the hypothesis that initial acute infection
stimulates type 1/pro-inflammatory cytokine expression followed by a gradual
type 2/anti-inflammatory response upon re-infection. This study analyzed
cytokine gene expression (interleukin-12, interferon-gamma, tumor necrosis
factor-alpha = type 1; interleukin-4, interleukin-10 = type 2) using a
semi-quantitative reverse transcriptase-polymerase chain reaction in monkeys
infected with each of the parasites (three per group). Clinicoparasitologic and
serologic parameters were also monitored. Monkeys were re-infected to assess
whether enhanced immunity could increase parasite clearance. The immune response to 
P. cynomolgi infection in rhesus monkeys seemed to be mediated by
anti-parasite, pro-inflammatory responses during primary infection with a
transition to protective type 2 responses after repeat infection. The immune
responses to P. knowlesi infection were more varied. Anti-inflammatory responses
were more prevalent during primary infection. Repeat infection stimulated a wide
variety of responses; most included expression of tumor necrosis factor-alpha, a
cytokine that has been associated with inflammatory and host-destructive effects
(weight loss, fever, anemia). These observations further confirmed that the
simian malaria/rhesus monkey model is well suited for studies on the regulation
of immunity to acute Plasmodium infection.
Am J Trop Med Hyg  2002 Dec;67(6):578-85 
Gambian children successfully treated with chloroquine can harbor and transmit
Plasmodium falciparum gametocytes carrying resistance genes.
Sutherland CJ, Alloueche A, Curtis J, Drakeley CJ, Ord R, Duraisingh M,
Greenwood BM, Pinder M, Warhurst D, Targett GA.
Department of Infectious and Tropical Diseases, London School of Hygiene and
Tropical Medicine, London, United Kingdom. [email protected]
Polymorphisms in two genes of Plasmodium falciparum (P. falciparum multidrug
resistance 1 [pfmdr1] and P. falciparum chloroquine [CQ] resistance transporter
[pfcrt]) are associated with CQ treatment failure. We found significant linkage
disequilibrium between these loci among isolates from symptomatic Gambian
children (P = 0.026) and strong selection for the resistance-associated alleles
pfmdr1-86Tyr and pfcrt-76Thr in children with persistent or re-emerging P.
falciparum trophozoites during post-treatment follow-up (P = 1.9 x 10(-7)).
Therefore, this genotype is characteristic of resistant infections among our
study population. Since the long-term public health impact of parasites carrying
such resistant genotypes depends upon their transmissibility, we examined the
prevalence of pfmdr1-86Tyr and pfcrt-76Thr among Gambian children harboring
sexual stage parasites during post-treatment follow-up. Gametocytes that emerged
after successful treatment with CQ were significantly more likely to be of this
genotype than were those emerging after other treatments (P = 4.83 x 10(-4)),
and were infective to Anopheles mosquitoes. Therapeutic success may thus be
accompanied by public health failure as cured children pass resistance genes on
to mosquitoes at an enhanced rate.
Am J Trop Med Hyg  2002 Dec;67(6):571-7 
A biologic basis for integrated malaria control.
McKenzie FE, Baird JK, Beier JC, Lal AA, Bossert WH.
Fogarty International Center, National Institutes of Health, Bethesda, Maryland
20892, USA. 
Email: [email protected]
In a series of models of Plasmodium falciparum dynamics, spontaneous local
extinctions of the parasite sometimes occurred under steady,
perennial-transmission conditions. These extinctions occurred only with
extremely low mosquito densities or when the parameter describing the duration
of human infection-blocking immunity was at its maximum value, and,
simultaneously, those describing vector survivorship and the duration of human
infectivity were at their minimum values. The range and frequency of extinctions
increased with seasonal transmission, and decreased with the emergence of
recombinant genotypes. Here we extend the immunity parameter up to levels that
would describe a successful vaccine, and examine the combined influences of
seasonality, genotype cross-reactivity, meiotic recombination, and human
population turnover on parasite persistence. As Ross did 90 years ago, we
conclude that malaria control programs that encompass several methods and
targets of intervention are the most likely to succeed. Success is more likely
if programs are cognizant of local circumstances of transmission, and, within
that context, aim to reduce vector survivorship and human infectivity as well as
augment human immunity.
Am J Trop Med Hyg  2002 Dec;67(6):566-70 
Prevalence of Plasmodium falciparum infection in pregnant Cameroonian women.
Zhou A, Megnekou R, Leke R, Fogako J, Metenou S, Trock B, Taylor DW, Leke RF.
Department of Biology, Georgetown University, Washington, District of Columbia
20057, USA.
Between 1995 and 1998, a longitudinal study was conducted at 2 health centers in
Cameroon to determine the prevalence of Plasmodium falciparum infection in
pregnant women. There were 520 pregnant women enrolled at a rural clinic in the
village of Etoa and 199 enrolled at the Biyem Assi Clinic in the city of
Yaounde. In Etoa, pregnant women were younger, fewer took prophylaxis, and
malaria prevalence was higher compared with pregnant women in the Biyem Assi
Clinic. The prevalence of malaria infection peaked during the fourth month of
pregnancy at both sites. Age was identified as a major risk factor because women
< or = 20 years old were 1.8 and 3.4 times more likely to have malaria infection
than women > 20 years old at Etoa and the Biyem Assi Clinic after adjusting for
gravidae and other factors. The use of chemoprophylaxis and seasonality did not
have a major effect.
Am J Trop Med Hyg  2002 Dec;67(6):563-5 
Short report: Failure of the OptiMAL rapid malaria test as a tool for the
detection of asymptomatic malaria in an area of Thailand endemic for 
Plasmodium falciparum and P. vivax.
Coleman RE, Maneechai N, Ponlawat A, Kumpitak C, Rachapaew N, Miller RS,
Sattabongkot J.
Department of Entomology, Armed Forces Research Institute of Medical Sciences,
Bangkok, Thailand. 
Email: [email protected]
We evaluated the efficacy of the OptiMAL assay in a cross-sectional malaria
survey in western Thailand from April to August 2001. Expert microscopy of
Giemsa-stained thick and thin blood films was used as the gold standard.
Positive control lines were evident in 99% (1,128 of 1,137) of the assays
tested. However, 34% (384 of 1,128) of assays produced an aberrant result (a
positive P. falciparum-specific line and a negative panmalarial line).
False-positive panmalarial and Plasmodium falciparum-specific lines occurred in
25.9% (270 of 1,042) and 60.3% (628 of 1,042) of microscopy-negative samples,
respectively. Due to the preponderance of false-positive test results, it was
necessary to develop subjective criteria for test positivity based on line
intensity. For determination of assay performance during this study, we
therefore considered all test lines that were scored as intermediate or strong
as positive and lines that were faint as negative. Using these criteria, we
determined that the sensitivity of the OptiMAL assay for P. falciparum was 25%
with > 500 parasites/microl and 10.5% with > 100 parasites/microl, while for P.
vivax, the sensitivity at the same parasite rates was 100% and 41.7%,
respectively. Further studies are required to determine whether the problems we
identified are limited to this particular lot of OptiMAL assays.
Am J Trop Med Hyg  2002 Dec;67(6):555-62 
Malaria infections are randomly distributed in diverse holoendemic areas of
Papua New Guinea.
Mehlotra RK, Kasehagen LJ, Baisor M, Lorry K, Kazura JW, Bockarie MJ, Zimmerman
Center for Global Health and Diseases, Case Western Reserve University School of
Medicine, Cleveland, Ohio 44106-4983, USA.
Malaria is holoendemic in the lowlands of Papua New Guinea (PNG), and
interactions among Plasmodium species may influence prevalence of mixed
infections. Previously, field samples from a cross-sectional survey in
Dreikikir, East Sepik Province, analyzed by blood smear and polymerase chain
reaction (PCR), showed that mixed infections were common and randomly
distributed in this malaria endemic region. To evaluate further whether
Plasmodium species distribution is random, blood smear- and
PCR/sequence-specific oligonucleotide probe hybridization-based analyses of
cross-sectional survey samples were conducted in 2 additional malaria
holoendemic regions of northern PNG. Despite ecologic, species prevalence, and
transmission season differences in these new surveys, all 4 Plasmodium species
were found to be randomly distributed in each area; random distribution patterns
also were observed when study populations were divided into age groups. These
findings provide consistent evidence that Plasmodium species infections occur
independently of one another in PNG malaria holoendemic sites. This independent
occurrence suggests that age-dependent, acquired malaria immunity has limited
influence on the distribution pattern of Plasmodium species infections in
endemic human populations; infection by 1 human malaria parasite species does
not reduce susceptibility to infection by others; and malaria vaccines would
exhibit limited protection against blood-stage infection by heterologous
Plasmodium species.
Clin Invest Med  2002 Dec;25(6):262-72 
Innate immunity to malaria caused by Plasmodium falciparum.
Smith TG, Ayi K, Serghides L, Mcallister CD, Kain KC.
Department of Medicine, Clinical Science Division, University of Toronto,
Toronto, Ont.
Malaria, a widespread disease caused by protozoa of the genus Plasmodium,
contributes to the death of more than 2 million people each year. Resistance to
antimalarial drugs is increasing, and an effective vaccine has not yet been
designed. In the search for alternative means to control malaria infections,
especially those caused by the most lethal species of malaria parasite,
Plasmodium falciparum, our attention has turned to elucidating the relationships
of the parasite and human host at the molecular level. In this review, we
describe possible mechanisms by which naturally occurring genetic mutations
might confer resistance to P. falciparum and how our innate immune response
mediated by the phagocytic action of monocytes and macrophages acts as a
first-line defence in clearing malaria infections. The potential effectiveness
of novel therapies to enhance innate phagocytic clearance of malaria parasites,
particularly in nonimmune people who are at greatest risk of adverse outcomes,
is also discussed.
Med Vet Entomol  2002 Dec;16(4):461-4 
Simultaneous identification of species and molecular forms of the Anopheles
gambiae complex by PCR-RFLP.
Fanello C, Santolamazza F, della Torre A.
London School of Hygiene and Tropical Medicine, London, UK.
For differential identification of sibling species in the Anopheles gambiae
Giles complex (Diptera: Culicidae), including simultaneous separation of M and S
molecular forms within An. gambiae Giles sensu stricto, we describe a PCR-RFLP
method. This procedure is more efficient, faster and cheaper than those used
before, so is recommended for large-scale processing of field-collected larval
and adult specimens to be identified in malaria vector studies.
Med Vet Entomol  2002 Dec;16(4):452-5 
In situ hybridization to the Rdl locus on polytene chromosome 3L of Anopheles stephensi.
Andreasen MH, Ffrench-Constant RH.
Department of Infectious & Tropical Diseases, London School of Hygiene &
Tropical Medicine, London, UK. 
Email: [email protected]
We are interested in generating a Y-autosome translocation of the Resistance to
dieldrin (Rdl) locus in the malaria vector mosquito Anopheles stephensi Liston
(Diptera: Culicidae), for use in sterile insect release. To ensure stability of
the system, a recombination suppressing inversion can also be induced which
encompasses the Rdl locus. As a first step, here we report the cloning of
fragments of the Rdl gene from both An. stephensi and An. gambiae Giles using
degenerate primers in the polymerase chain reaction. These fragments encode the
second membrane-spanning region of the gamma-aminobutyric acid receptor and 
show high levels of both nucleotide and predicted amino acid identity to other
Rdl-like receptors. They confirm that, as in all other arthropod species
examined, dieldrin resistance in An. stephensi is associated with replacement of
alanine302, in this case with a serine. In situ hybridization of the Rdl probe
to polytene chromosomes of An. stephensi localizes the gene to the left arm of
chromosome 3 (3L) in region 45C. Rdl localization will enable us to identify
chromosomal rearrangements encompassing the Rdl locus and help anchor the genome sequence of An. gambiae to the polytene map.
Med Vet Entomol  2002 Dec;16(4):404-8 
Insecticide-treated plastic tarpaulins for control of malaria vectors in refugee camps.
Graham K, Mohammad N, Rehman H, Nazari A, Ahmad M, Kamal M, Skovmand O,
Guillet P, Allan R, Zaim M, Yates A, Lines J, Rowland M.
HealthNet International, Peshawar, Pakistan.
Spraying of canvas tents with residual pyrethroid insecticide is an established
method of malaria vector control in tented refugee camps. In recent years,
plastic sheeting (polythene tarpaulins) has replaced canvas as the utilitarian
shelter material for displaced populations in complex emergencies. Advances in
technology enable polythene sheeting to be impregnated with pyrethroid during
manufacture. The efficacy of such material against mosquitoes when erected as
shelters under typical refugee camp conditions is unknown. Tests were undertaken
with free-flying mosquitoes on entomological study platforms in an Afghan
refugee camp to compare the insecticidal efficacy of plastic tarpaulin sprayed
with deltamethrin on its inner surface (target dose 30 mg/m2), tarpaulin
impregnated with deltamethrin (initially > or = 30 mg/m2) during manufacture,
and a tent made from the factory impregnated tarpaulin material. Preliminary
tests done in the laboratory with Anopheles stephensi Liston (Diptera:
Culicidae) showed that 1-min exposure to factory-impregnated tarpaulins would
give 100% mortality even after outdoor weathering in a temperate climate for 12
weeks. Outdoor platform tests with the erected materials (baited with human
subjects) produced mosquito mortality rates between 86-100% for sprayed or
factory-impregnated tarpaulins and tents (average approximately 40 anophelines
and approximately 200 culicines/per platform/night), whereas control mortality
(with untreated tarpaulin) was no more than 5%. Fewer than 20% of mosquitoes
blood-fed on human subjects under either insecticide-treated or non-treated
shelters. The tarpaulin shelter was a poor barrier to host-seeking mosquitoes
and treatment with insecticide did not reduce the proportion blood-feeding. Even
so, the deployment of insecticide-impregnated tarpaulins in refugee camps, if
used by the majority of refugees, has the potential to control malaria by
killing high proportions of mosquitoes and so reducing the average life
expectancy of vectors (greatly reducing vectorial capacity), rather than by
directly protecting refugees from mosquito bites. Mass coverage with
deltamethrin-sprayed or impregnated tarpaulins or tents has strong potential for
preventing malaria in displaced populations affected by conflict.
Med Vet Entomol  2002 Dec;16(4):347-55 
Stream-bank shade and larval distribution of the Philippine malaria vector
Anopheles flavirostris.
Foley DH, Torres EP, Mueller I.
Tropical Health Program, Department of Zoology and Entomology, The University of
Queensland, Brisbane, Australia. 
Email: [email protected]
The principal malaria vector in the Philippines, Anopheles flavirostris (Ludlow)
(Diptera: Culicidae), is regarded as 'shade-loving' for its breeding sites, i.e.
larval habitats. This long-standing belief, based on circumstantial observations
rather than ecological analysis, has guided larval control methods such as
'stream-clearing' or the removal of riparian vegetation, to reduce the local
abundance of An. flavirostris. We measured the distribution and abundance of An.
flavirostris larvae in relation to canopy vegetation cover along a stream in
Quezon Province, the Philippines. Estimates of canopy openness and light
measurements were obtained by an approximation method that used simplified
assumptions about the sun, and by hemispherical photographs analysed using the
program HEMIPHOT. The location of larvae, shade and other landscape features was
incorporated into a geographical information system (GIS) analysis. Early larval
instars of An. flavirostris were found to be clustered and more often present in
shadier sites, whereas abundance was higher in sunnier sites. For later instars,
distribution was more evenly dispersed and only weakly related to shade. The
best predictor of late-instar larvae was the density of early instars.
Distribution and abundance of larvae were related over time (24 days). This
pattern indicates favoured areas for oviposition and adult emergence, and may be
predictable. Canopy measurements by the approximation method correlated better
with larval abundance than hemispherical photography, being economical and
practical for field use. Whereas shade or shade-related factors apparently have
effects on larval distribution of An. flavirostris, they do not explain it
completely. Until more is known about the bionomics of this vector and the
efficacy and environmental effects of stream-clearing, we recommend caution in
the use of this larval control method.

+ Sources

Tnhealth has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical associations. We work mostly with peer-reviewed studies to ensure accurate information. We avoid using tertiary references. You can learn more about how we ensure our content is accurate and current by reading our editorial policy.


Related post